ClinicalTrials.gov
public full text
Public Domain
Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
Exploring the therapeutic effect of neoadjuvant chemotherapy combined with PD-1 inhibitor camrelizumab on advanced stage III-IV endometrial cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer#897088
- Improving the Treatment for Women With Early Stage Cancer of the Uterus#175088
- QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer#1195547
- Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy#852009
- PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer#892403
Record · ID 1339531
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive